News
The registry recently enrolled its first European Union patient, expanding its geographic footprint of enrollment beyond North America, where the first patient was enrolled in December 2023. The registry addresses a critical unmet need for real-world evidence and adolescent-specific…
Newswise — Researchers from the George Washington University and Virginia Tech, have uncovered a significant connection between primary hyperhidrosis, a condition of excessive sweating, and sensitive skin, where skin overreacts to stimuli like sweat and stress.
The study, led by Adam…
Deodorant and antiperspirant sound like the same product and people use them to accomplish the same basic mission: stop underarm body odor. Both options can be effective, but they work in different ways.
Is one healthier than the other? For something that goes in your armpit, there’s a lot…
Dermatologists outline unmet needs in the treatment landscape for atopic dermatitis and discuss how to potentially improve the standard of care for patients with atopic dermatitis.
Eli Lilly’s announcement of the lebrikizumab-lbkz approval for patients 12 years of age and older follows positive findings from the ADvocate 1, ADvocate 2, and ADhere studies.
Nemolizumab shows early and sustained benefits in reducing itch and sleep disturbance in moderate-to-severe atopic dermatitis, per ARCADIA data.
GW University Chair of Dermatology and professor Dr. Adam Friedman joined Good Day DC with some tips on how you can take care of your skin now that school is back in session.
"Don’t scratch" is probably one of the best—and worst—pieces of advice an eczema patient can receive. The skin condition, which is caused by an abnormal immune reaction that results in dry, red, cracked patches of skin, is only made worse by itching. Your nails damage the skin barrier, which…
Jonathan Silverberg, MD, PhD, MPH, offers insights on the role of patient-reported outcomes in informing treatment decisions for patients with atopic dermatitis.
Janus kinase (JAK) inhibitors have had game-changing effects for patients with psoriasis, atopic dermatitis, vitiligo, and alopecia areata, but the use of these potent medications has been associated with JAK inhibitor-associated acne (JAKne).
In a systematic review and meta-analysis of 25…